Arne Scheu

Company: Valink Therapeutics

Job title: CEO

Seminars:

Spotlighting Synergy: Embracing High-Throughput Discovery & Development of Monospecific & Bispecific Drug Conjugates 11:00 am

Outlining a approach to conjugate design, where equal emphasis is placed on optimizing each component – from payload to linker to targeting binders Discussing the transformative potential of bispecific drug-conjugates, including bispecific ADCs (bsADCs) Showcasing innovative methodology enabling rapid iteration and high-throughput screening of conjugates, allowing for the creation of thousands of candidates in mere…Read more

day: Day One